Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Doxacurium chloride is a nondepolarizing neuromuscular blocking agent used as an adjunct to general anesthesia to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgical procedures. A medication that has been used to relax muscles and open airways during anesthesia for surgery.
- Mechanism
- Curator reviewed
Doxacurium chloride binds competitively to cholinergic receptors on the motor end-plate to antagonize the action of acetylcholine, resulting in a block of neuromuscular transmission (non-depolarizing). This action is antagonized by acetylcholinesterase inhibitors, such as neostigmine.
- Primary indication
- Used to provide skeletal muscle relaxation as an adjunct to general anesthesia, for endotracheal intubation or to facilitate mechanical ventilation.Curator reviewed
- Formula / weight
- C56H78N2O16 · 1035.2223 g/mol (avg)
- First approval
- Canada, 2012 · United States, 2010
Resolves to
GBLRQXKSCRCLBZ-UHFFFAOYSA-NSMILESCOC1=CC(CC2C3=C(OC)C(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C(OC)=C3C2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OCWhat you can answer from here — as of August 31, 2026
Which drugs share a target with Doxacurium chloride, and which of those have an active Phase 3 trial?